FDA Extends Deadline on Electrical Stimulation Device Ban to November
FDA postpones electric-shock device ban decision to November, leaving Judge Rotenberg Center patients exposed. Prior 2020 ban was overturned on procedure; no new efficacy data support continued use. Regulatory timeline reflects litigation risk rather than fresh clinical findings.
The extension follows a pattern of regulatory caution after prior judicial reversals and mirrors delays seen in other high-profile device and drug re-evaluations where patient advocacy and institutional resistance intersect. Absent new clinical endpoints or safety signals, the November deadline will test whether the agency can produce an evidence-based rationale capable of surviving another court challenge.
FDA: Will issue a new proposed ban or final denial by 15 November 2026 with explicit clinical endpoints required for any future exceptions.
Sources (3)
- [1]FDA Federal Register: Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior(https://www.federalregister.gov/documents/2020/03/06/2020-04328/ban-on-electrical-stimulation-devices)
- [2]U.S. District Court Ruling Vacating 2020 Ban(https://www.courtlistener.com/docket/5967847/the-judge-rotenberg-center-v-fda/)
- [3]UN Special Rapporteur Report on Torture and Disability(https://www.ohchr.org/en/documents/thematic-reports/a76150-report-special-rapporteur-torture-and-other-cruel-inhuman-or-degrading)